436 total citations 28 papers, 377 citations indexed
About
Vogler Wr is a scholar working on Oncology, Molecular Biology and Epidemiology.
According to data from OpenAlex, Vogler Wr has authored 28 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Vogler Wr's work include Acute Myeloid Leukemia Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Neutropenia and Cancer Infections (4 papers). Vogler Wr is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Neutropenia and Cancer Infections (4 papers). Vogler Wr collaborates with scholars based in United States and Germany. Vogler Wr's co-authors include Stanley Zucker, Daniel Rudman, Bettye Hollins, Leslie Glasser, Frederick W. Miller, Ralph D. Reynolds, Paul W. Sternberg, Theodore F. Logan, R. Korth and Hiroaki Nomura and has published in prestigious journals such as PubMed.
In The Last Decade
Vogler Wr
28 papers
receiving
333 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Vogler Wr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vogler Wr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vogler Wr more than expected).
This network shows the impact of papers produced by Vogler Wr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vogler Wr. The network helps show where Vogler Wr may publish in the future.
Co-authorship network of co-authors of Vogler Wr
This figure shows the co-authorship network connecting the top 25 collaborators of Vogler Wr.
A scholar is included among the top collaborators of Vogler Wr based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Vogler Wr. Vogler Wr is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Glasser, Leslie, et al.. (1996). Response of human multiple myeloma-derived cell lines to alkyl-lysophospholipid.. PubMed. 24(2). 253–7.7 indexed citations
2.
Shoji, Mikio, et al.. (1994). Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.. PubMed. 22(1). 13–8.10 indexed citations
3.
Wr, Vogler, et al.. (1992). Alkyl-lysophospholipid purging for autologous bone marrow transplantation in acute leukemia in second or subsequent remission after extramedullary relapse.. PubMed. 377. 79–85.2 indexed citations
4.
Wr, Vogler, et al.. (1987). Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids.. PubMed. 15(4). 360–4.13 indexed citations
5.
Wr, Vogler, et al.. (1986). Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study.. PubMed. 70(4). 455–9.17 indexed citations
6.
Wr, Vogler, et al.. (1985). Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.. PubMed. 13(7). 629–33.54 indexed citations
7.
Miller, Frederick W., et al.. (1984). Abnormal profile of serum proteinase inhibitors in cancer patients.. PubMed. 44(6). 2718–23.27 indexed citations
8.
Wr, Vogler, et al.. (1984). The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells.. PubMed. 12(7). 569–74.11 indexed citations
9.
Wr, Vogler, et al.. (1983). Phase II study of amsacrine gluconate in refractory leukemia.. PubMed. 67(12). 1131–2.9 indexed citations
10.
Wr, Vogler, et al.. (1982). Influence of quantity of granulocytes transfused on response.. PubMed. 88. 75–91.7 indexed citations
11.
Wr, Vogler, et al.. (1981). Collection and transfusion of granulocytes from stimulated donors.. PubMed. 65. 29–40.2 indexed citations
12.
Wr, Vogler, et al.. (1981). Temporal correlation of the marrow's production of granulopoietic stimulatory activity and granulocyte regeneration after vinblastine.. PubMed. 9(6). 619–27.2 indexed citations
13.
Rudman, Daniel, et al.. (1979). Proteinuria with disseminated neoplastic disease.. PubMed. 39(3). 699–703.7 indexed citations
14.
Wr, Vogler, et al.. (1979). Treatment of refractory adult acute leukemia with 5-azacytidine plus beta-2'-deoxythioguanosine.. PubMed. 63(2). 209–10.5 indexed citations
15.
Wr, Vogler, et al.. (1979). Colony stimulating activity and continuous flow centrifugation leukapheresis induced proteinuria.. PubMed. 7(1). 27–35.5 indexed citations
16.
Wr, Vogler, et al.. (1978). Phase I study of pyrazofurin in refractory acute myelogenous leukemia.. PubMed. 62(10). 1569–71.7 indexed citations
17.
Vélez-García, E, et al.. (1977). Twice weekly 5-azacytidine infusion in dissmeinated metastatic cancer: a phase II study.. PubMed. 61(9). 1675–7.8 indexed citations
18.
Wr, Vogler, et al.. (1976). Synchronization with phase-specific agents in leukemia and correlation with clinical response to chemotherapy.. PubMed. 60(12). 1845–59.9 indexed citations
19.
Wr, Vogler, et al.. (1975). Humoral granulopoietic inhibitors: a review.. PubMed. 3(6). 337–53.11 indexed citations
20.
Rudman, Daniel, et al.. (1972). An abnormal orosomucoid in the plasma of patients with neoplastic disease.. PubMed. 32(9). 1951–9.38 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.